Niemann Pick Disease Type C1 clinical trials

Explore recruiting niemann pick disease type c1 clinical trials.

Recruiting niemann pick disease type c1 studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Niemann Pick Disease Type C1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of 2000 mg/kg of Trappsol® Cyclo™ (Hydroxypropyl-β-cyclodextrin) and Standard of Care Compared to Placebo and Standard of Care in Patients with Niemann-Pick Disease Type C1

Italy, Poland, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Niemann Pick Disease Type C1 trials by city

Niemann Pick Disease Type C1 in Toronto Niemann Pick Disease Type C1 in Vancouver Niemann Pick Disease Type C1 in Montreal Niemann Pick Disease Type C1 in Calgary Niemann Pick Disease Type C1 in Edmonton Niemann Pick Disease Type C1 in Ottawa Niemann Pick Disease Type C1 in Winnipeg Niemann Pick Disease Type C1 in Quebec City Niemann Pick Disease Type C1 in Hamilton Niemann Pick Disease Type C1 in Kitchener Niemann Pick Disease Type C1 in London Niemann Pick Disease Type C1 in Halifax Niemann Pick Disease Type C1 in New York Niemann Pick Disease Type C1 in Los Angeles Niemann Pick Disease Type C1 in Chicago Niemann Pick Disease Type C1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease